Information needed to decide about cardiovascular treatment in primary care

J Robson1

  • 1Academic Department of General Practice, St Bantholonew's, London.

BMJ (Clinical Research Ed.)
|January 25, 1997
PubMed

Insights

Cardiovascular risk management should prioritize absolute risk assessment over relative risk. This approach helps clinicians and patients weigh treatment benefits against hazards for personalized care decisions.

Area of Science:

  • Cardiology
  • Primary Care Medicine
  • Health Decision Science

Background:

  • Current cardiovascular risk management trends favor multifactorial and absolute risk assessment over single factors and relative risks.
  • Establishing appropriate treatment thresholds requires balancing the benefits and hazards of intervention versus non-intervention.
  • Accurate patient absolute risk is crucial for informed treatment decisions in primary care.

Purpose of the Study:

  • To review methods for aiding clinical decision-making in primary care for cardiovascular disease.
  • To emphasize the importance of considering absolute risk when initiating treatment programs.
  • To explore how to present treatment outcomes (benefits, hazards, costs) for various absolute risk levels.

Main Methods:

  • Review of existing measures and guidelines for cardiovascular risk assessment and treatment decisions.
  • Focus on presenting treatment outcomes in relation to a patient's absolute risk.
  • Utilizing cardiovascular disease as a case study for decision-making tools.

Main Results:

  • The study highlights the need for accessible presentations of treatment benefits, hazards, and costs across a spectrum of absolute risks.
  • Decision-making tools should facilitate the comparison of treatment pros and cons for individual patients.
  • Practice guidelines should incorporate these measures to support shared decision-making.

Conclusions:

  • Personalized cardiovascular risk management necessitates a shift towards absolute risk evaluation.
  • Accessible data on treatment outcomes empowers patients and clinicians in shared decision-making.
  • Integrating benefit-hazard-cost analyses into guidelines can optimize primary care for cardiovascular disease prevention.

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...